这条路,就是公路.

Same author

Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease.

Blood·2020

Same author

Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.

International journal of radiation oncology, biology, physics·2017

Same author

Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.

JAMA dermatology·2016

Same author

Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane.

The journal of allergy and clinical immunology. In practice·2015

Same author

Onchocerciasis or loiasis?

Lancet (London, England)·2007

Same author

UV hardening therapy: a novel intervention in patients with photosensitive cutaneous lupus erythematosus.

Journal of the American Academy of Dermatology·2006

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

这条路,就是公路.

相关概念视频

Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease.

Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.

Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.

Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane.

Onchocerciasis or loiasis?

UV hardening therapy: a novel intervention in patients with photosensitive cutaneous lupus erythematosus.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

这条路,就是公路.

相关概念视频

相关文章

Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease.

Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.

Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.

Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane.

Onchocerciasis or loiasis?

UV hardening therapy: a novel intervention in patients with photosensitive cutaneous lupus erythematosus.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.